Business Context and Reporting Period
Zimmer Holdings, Inc. (now Zimmer Biomet Holdings, Inc.) filed this Form 8-K on January 26, 2012, to report its results of operations for the quarter and full year ended December 31, 2011. The filing incorporates by reference an earnings release (Exhibit 99.1) containing detailed financial data.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. It references an attached press release for these figures. The report highlights the use of non-GAAP financial measures, specifically:
- Constant Currency Sales: Sales translated at predetermined exchange rates to exclude foreign currency fluctuations.
- Adjusted Net Earnings and Diluted EPS: Metrics excluding inventory step-up, special items, and specific provisions.
Material Changes and Adjustments
The filing details specific adjustments made to non-GAAP measures to facilitate period-to-period comparisons:
- 2011 Adjustments: Excluded inventory step-up, special items (acquisition/integration costs, restructuring, termination benefits), and a provision for claims related to the Durom Acetabular Component. Full-year 2011 also excluded tax adjustments from resolved tax matters.
- 2010 Adjustments: Excluded inventory step-up, special items, the Durom provision, and a goodwill impairment charge related to the U.S. Spine business.
Guidance, Outlook, and Risks
The filing notes that the attached earnings release includes projected adjusted diluted EPS for the full year 2012. Management utilizes these non-GAAP measures for internal performance evaluation and incentive compensation. Key risks and contingencies identified include:
- Product Liability: Provisions for known and anticipated claims regarding the Durom Acetabular Component.
- Restructuring: Costs associated with global restructuring and transformation initiatives.
- Tax Matters: Adjustments related to the resolution of certain tax issues.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific GAAP and non-GAAP revenue, earnings, and EPS figures.
- Verify the reconciliation between non-GAAP adjusted earnings and GAAP net earnings.
- Assess the magnitude of the provision for Durom Acetabular Component claims.
- Confirm the projected adjusted diluted EPS for 2012 and the assumptions underlying it.
- Examine the details of the goodwill impairment charge related to the U.S. Spine business in the 2010 comparison period.